Status:

UNKNOWN

Individual Neuromodulation for PDS

Lead Sponsor:

Ruijin Hospital

Conditions:

Neuromodulation

Parkinsonian Syndromes

Eligibility:

All Genders

40-80 years

Phase:

NA

Brief Summary

Parkinsonian Syndromes (PDS) with predominant motor dysfunction include progressive supranuclear palsy (PSP), multiple system atrophy (MSA) and corticobasal degeneration (CBD). Current treatment optio...

Eligibility Criteria

Inclusion

  • Compliance with the MDS revised clinical diagnostic criteria for Parkinsonian syndrome (2015 edition)
  • aged \>40 years and \<80 years, regardless of gender.
  • Patients were relatively stable during the study period and remained stable on medication
  • Good compliance, written informed consent, and consent for NIBS long-term intervention treatment

Exclusion

  • Patients with severe neuropsychiatric disorders or a previous history of severe neurologic conditions (e.g., epilepsy, cerebrovascular accident, etc.) or traumatic brain injury or brain surgery
  • inability to complete the questionnaire independently
  • Previous treatment with DBS or SCS; TMS or tDCS within 6 months
  • Severe physical illness and any physical condition that can precipitate epilepsy or intracranial hypertension, including cardiovascular and respiratory diseases
  • Installation of intracranial stents, pacemakers, coronary stents, cochlear implants, and other human implantable materials
  • is currently taking other investigational drugs or is participating in other clinical trials
  • Any other condition that the investigator believes makes him or her unsuitable for participation in this study.

Key Trial Info

Start Date :

September 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06193278

Start Date

September 1 2023

End Date

June 30 2025

Last Update

January 10 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China, 200025